EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Mediastinum

ISSN 2522-6711 · AME Publishing Company

Latest articles

  1. AB008. Final analysis from PECATI phase 2 trial: lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma

    Jordi Remon, Paolo Bironzo, Nicolas Girard, Laurence Bigay-Game, Oscar Juan-Vidal, Javier de Castro, Noemí Reguart, Laurent Greillier, Sophie Cousin, Eric Dansin, Margarita Majem, Reyes Bernabé, Joaquin Mosquera Martinez, Marta Díaz, Alba Meya, Daniel Alcalá-López, Alicia García-Sanz, Luisella Righi, Silvia Novello, Benjamin Besse

    Published: 2026-10DOI: 10.21037/med-26-ab008

Volumes

2026 · 882025 · 962024 · 1162023 · 692022 · 542021 · 632020 · 412019 · 422018 · 942017 · 79

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.